1st Quarter - Termination

FABIANI & COMPANY for VAXINNATE

Firm
Client
Income
—
Expenses
—
Terminated
Apr 30, 2009

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 17, 2009 $60,000 Yes
1st Quarter - Termination (this page) Jul 17, 2009 — Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
JAMES P FABIANI —
WENDY SHELTON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Budget/Appropriations BUD

Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
JAMES P FABIANI —
WENDY SHELTON —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
JAMES P FABIANI —
WENDY SHELTON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.